Search results for "Marr"

showing 10 items of 776 documents

Targeting cells of the immune system: mannosylated HPMA–LMA block-copolymer micelles for targeting of dendritic cells

2016

Background: Successful tumor immunotherapy depends on the induction of strong and sustained tumor antigen-specific immune responses by activated antigen-presenting cells (APCs) such as dendritic cells (DCs). Since nanoparticles have the potential to codeliver tumor-specific antigen and DC-stimulating adjuvant in a DC-targeting manner, we wanted to assess the suitability of mannosylated HPMA-LMA block polymers for immunotherapy. Materials & methods: Fluorescence-labeled block copolymer micelles derived from P(HPMA)-block-P(LMA) copolymers and according statistical copolymers were synthesized via RAFT polymerization, and loaded with the APC activator L18-MDP. Both types of copolymers wer…

Materials sciencePolymersSurface Propertiesmedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)Bone Marrow CellsBioengineering02 engineering and technologyDevelopment01 natural sciencesMicellePolymerizationImmune systemAntigenmedicineHumansGeneral Materials ScienceReversible addition−fragmentation chain-transfer polymerizationMicelles010405 organic chemistryDendritic CellsImmunotherapyDendritic cell021001 nanoscience & nanotechnologyMolecular biology0104 chemical sciencesCell biologyMethacrylatesNanoparticlesImmunotherapy0210 nano-technologyAcetylmuramyl-Alanyl-IsoglutamineMannoseAdjuvantSpleenMannose receptorNanomedicine
researchProduct

Immobilization of BMP‐2, BMP‐7 and alendronic acid on titanium surfaces: Adhesion, proliferation and differentiation of bone marrow‐derived stem cells

2019

This study analyzed the influence of titanium (TiO2 ) surface modifications with two osteogenic proteins (BMP-2, BMP-7) and an anti-osteoclastic drug (alendronic acid [AA]) on sandblasted/acid-etched (SLA) and plain TiO2 (PT) on cell adhesion, proliferation and differentiation (alkaline phosphatase [AP] and osteocalcin [OC]) of bone-marrow derived stem cells (BMSCs) after 1, 3 and 7 days in-vitro. Initially, AA surfaces showed the highest cell number and surface coverage. At day 3 and 7, BMP and AA-modified surfaces exhibited a significantly enhanced cell growth. For proliferation, at days 3 and 7, an enhancement on BMP-2, BMP-7 and AA-surfaces was seen. At day 7, SLA also showed a higher p…

Materials scienceSurface PropertiesBone Morphogenetic Protein 70206 medical engineeringBiomedical EngineeringBone Morphogenetic Protein 2Biocompatible MaterialsBone Marrow Cells02 engineering and technologyBone morphogenetic protein 2BiomaterialsOsteogenesisCell AdhesionmedicineHumansCell adhesionCells CulturedCell ProliferationTitaniumAlendronateBone Density Conservation AgentsbiologyCell growthStem CellsAlendronic acidfungiMetals and AlloysCell DifferentiationAdhesion021001 nanoscience & nanotechnology020601 biomedical engineeringMolecular biologyImmobilized Proteinsmedicine.anatomical_structureembryonic structuresCeramics and CompositesOsteocalcinbiology.proteinAlkaline phosphataseBone marrow0210 nano-technologymedicine.drugJournal of Biomedical Materials Research Part A
researchProduct

Matteo Marrone (13.10.1929 - 8.4.2020)

2020

Commenmorazione di Matteo Marrone

Matteo MarroneLauro ChiazzeseBernardo AlbaneseSettore IUS/18 - Diritto Romano E Diritti Dell'Antichita'Salvatore Riccobono
researchProduct

Scritti per il novantesimo compleanno di Matteo Marrone

2019

Matteo MarroneSettore IUS/18 - Diritto Romano E Diritti Dell'Antichita'
researchProduct

Dynamics of CXC group chemokine platelet factor 4 (PF4) plasma levels in non-small cell lung cancer (NSCLC)

2012

CXC chemokines display pleiotropic effects participating not only in inflammation, but regulating angiogenesis and metastatic spread in cancer. Platelet factor 4 (PF4) is a 70-amino acid protein belonging to the CXC chemokine family. PF4 is also known as CXCL4. This chemokine is released from alpha-granules of activated platelets and binds with high affinity to heparin-like molecules promoting coagulation. Megakaryocytes respond to the presence of tumors by increasing their number in the bone marrow accompanied by increase in the number of platelets in circulation, causing changes in chemokine balance.

Medicine(all)ChemokinebiologyBiochemistry Genetics and Molecular Biology(all)Angiogenesisbusiness.industrylcsh:Rlcsh:MedicineCancerInflammationGeneral Medicinemedicine.diseaseGeneral Biochemistry Genetics and Molecular Biologymedicine.anatomical_structurePoster PresentationImmunologymedicinebiology.proteinPlateletPlatelet activationBone marrowmedicine.symptombusinessPlatelet factor 4Journal of Translational Medicine
researchProduct

CD28, a marker associated with tumoral expansion in multiple myeloma

1998

International audience; CD28 expression was thoroughly investigated on plasma cells of monoclonal gammopathy of undetermined significance, multiple myeloma (MM), and human myeloma cell lines. CD28+ plasma cells were detected in 19% of 31 monoclonal gammopathy of undetermined significance, 41% of 116 MM, and 100% of 13 human myeloma cell lines. CD28+ myeloma cells were detected in 21 of 79 (26%) MM cases at diagnosis, 13 of 22 (59%) at medullary relapse (P < 0.009), and 14 of 15 (93%) at extramedullary relapse (P = 0.05), including 10 of 10 (100%) secondary plasma cell leukemias (P = 0.05). Serial studies in individual patients confirmed the emergence of CD28+ myeloma cells with tumoral expa…

Membrane GlycoproteinsParaproteinemiasNeoplasms Second Primarychemical and pharmacologic phenomenahemic and immune systemsCD56 AntigenCell LineLeukemia Plasma CellCD28 AntigensAntigens CDBone MarrowPredictive Value of TestsRecurrence[ INFO.INFO-BI ] Computer Science [cs]/Bioinformatics [q-bio.QM]hemic and lymphatic diseasesB7-1 AntigenBiomarkers TumorDisease ProgressionTumor Cells CulturedHumansB7-2 AntigenTreatment Failure[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]Multiple Myeloma[INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM]
researchProduct

Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishman…

2007

Background To overcome some of the limitations of conventional microbiologic techniques, polymerase chain reaction (PCR)-based assays are proposed as useful tools for the diagnosis of visceral leishmaniasis. Patients and methods A comparative study using conventional microbiologic techniques (i.e., serologic testing, microscopic examination, and culture) and a Leishmania species-specific PCR assay, using peripheral blood and bone marrow aspirate samples as templates, was conducted during an 8-year period. The study cohort consisted of 594 Italian immunocompetent (adult and pediatric) and immunocompromised (adult) patients experiencing febrile syndromes associated with hematologic alteration…

Microbiology (medical)AdultMalePathologymedicine.medical_specialtyHepatosplenomegalyHIV InfectionsPolymerase Chain ReactionSensitivity and Specificitylaw.inventionSerologyImmunocompromised HostlawBone MarrowBiopsymedicineAnimalsHumansSerologic TestsProspective StudiesChildPolymerase chain reactionAgedLeishmaniamedicine.diagnostic_testAIDS-Related Opportunistic Infectionsbusiness.industryInfantLeishmaniasisMiddle Agedmedicine.diseaseInfectious Diseasesmedicine.anatomical_structureVisceral leishmaniasisPCRItalyChild PreschoolImmunologyLeishmaniasis VisceralFemaleBone marrowViral diseasemedicine.symptombusinessAlgorithms
researchProduct

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.

2009

OBJECTIVES: Caspofungin was evaluated as first-line monotherapy of invasive aspergillosis (IA) in patients with haematological malignancies and undergoing autologous transplants. METHODS: Adults with proven or probable IA, defined strictly according to EORTC-MSG criteria, were eligible. Those with possible IA were enrolled, but were not evaluable for efficacy unless upgraded to proven/probable disease within 7 days of registration based on investigations performed within 48 h after enrolment. Caspofungin dosage was 70 mg (day 1) followed by 50 mg/day. The primary endpoint was the proportion of patients with complete or partial response at the end of caspofungin therapy in the modified inten…

Microbiology (medical)AdultMalemedicine.medical_specialtyAntifungal AgentsNeutropeniaAspergillosisGastroenterologyTransplantation Autologouschemistry.chemical_compoundEchinocandinsLipopeptidesYoung AdultCaspofunginInternal medicineClinical endpointmedicineAspergillosisHumansPharmacology (medical)Survival rateSurvival analysisAgedPharmacologyAged 80 and overSurrogate endpointbusiness.industryMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryTransplantationAcute Leukaemia; Fungal Infections; Echinocandins; Bone-Marrow-Transplantation; Stem-Cell Transplants; Mycoses Study-Group; Fungal-Infections; Prognostic-Factors; European-Organization; Amphotericin-B; Consensus; Epidemiology; VoriconazoleInfectious DiseasesTreatment OutcomechemistryHematologic NeoplasmsFemaleCaspofunginbusinessThe Journal of antimicrobial chemotherapy
researchProduct

Role of hematopoietic cells in Mycobacterium tuberculosis infection.

2021

Tuberculosis remains one of the most significant causes of mortality worldwide and the current situation shows a re-emergence of TB due to the emergence of new antibiotic-resistant strains and the widespread of disease caused by immunodeficiencies. For these reasons, a big effort is made to improve the therapeutic strategies against Mycobacterium tuberculosis and to perform new therapeutic and diagnostic strategies. This review analyzes the various hematopoietic populations, their role and the different changes they undergo during Mycobacterium tuberculosis infection or disease. We have examined the population of lymphocytes, monocytes, neutrophils, eosinophils and platelets, in orderto und…

Microbiology (medical)Blood PlateletsMyeloidTuberculosisNeutrophilsImmunologyPopulationDiseaseMicrobiologyMonocytesMycobacterium tuberculosismedicineHumansTuberculosisLymphocytesProgenitor celleducationeducation.field_of_studyHematopoietic cellsbiologybusiness.industryMycobacterium tuberculosismedicine.diseasebiology.organism_classificationHematopoietic Stem CellsEosinophilsInfectious Diseasesmedicine.anatomical_structureImmunologyMyeloid cellsBone marrowStem cellbusinessLymphoid cellsTuberculosis (Edinburgh, Scotland)
researchProduct

Modulation of accessory cell function of immortalized bone marrow-derived macrophages by granulocyte/macrophage colony-stimulating factor.

1993

To generate cloned macrophage populations with sensitivity towards granulocyte/macrophage colony-stimulating factor (GM-CSF), bone marrow-derived macrophages (BMM phi) were immortalized by transformation with SV40. A panel of transformed clones was established. The majority of clones represented independently derived transformants, as evidenced by restriction fragment length polymorphism using genomic DNA digested with EcoRI and TaqI and the 5.2 kb SV40 DNA for hybridization analysis. The cells belong to the macrophage lineage according to several criteria, e.g. the presence of nonspecific esterase, their phagocytic capacity and their morphology. Many clones were potent antigen-presenting c…

Microbiology (medical)ImmunologyAntigen presentationAntigen-Presenting CellsBone Marrow CellsSimian virus 40BiologyGranulocyteMicePhagocytosismedicineImmunology and AllergyMacrophageAnimalsAntigen-presenting cellCells CulturedMice Inbred C3HMacrophage Colony-Stimulating FactorMacrophagesHistocompatibility Antigens Class IIGranulocyte-Macrophage Colony-Stimulating FactorGeneral MedicineBlotting NorthernCell Transformation ViralMolecular biologyClone CellsBlotmedicine.anatomical_structureGranulocyte macrophage colony-stimulating factorCell cultureImmunologyDNA ViralBone marrowDNA ProbesPolymorphism Restriction Fragment Lengthmedicine.drugMedical microbiology and immunology
researchProduct